Sign In
Buy ADC
$72.03
-0.650 (-0.89%)
At Close: Jun 03, 2026
Whitehawk Therapeutics Presents Comprehensive Preclinical Data Highlighting its Next-Generation ADC Portfolio at the AACR 2026
06:00pm, Sunday, 19'th Apr 2026
Data demonstrate preclinical proof-of-concept for HWK-007, HWK-016 and HWK-206, underpinned by Whitehawk's proprietary Carbon Bridge Cysteine Re-pairing platform Tumor regressions observed across vari
I Never Knew My First Develop Deal Would Lead To A $231 Billion Marketplace
08:00am, Sunday, 19'th Apr 2026
Realty Income and VICI Properties are highlighted as top net lease REITs with wide moats and attractive valuations. Net lease REITs benefit from long-term, predictable cash flows and cost-of-capital a
Onvansertib in combination with trastuzumab deruxtecan demonstrated enhanced antitumor activity, including tumor regression and apoptosis in HER2-low breast cancer models, supporting its potential for
Boomers and Gen X Love Passive Income From 5 of the Safest Monthly Dividend Stocks
08:48am, Thursday, 16'th Apr 2026
Passive income is revenue generated without the earner's continuous active effort, making it a desirable financial strategy for those seeking to diversify their income streams or achieve financial ind
A High-Yield REIT Strategy For Long-Term Income Investors
07:15am, Thursday, 16'th Apr 2026
High yields often hide trouble, and blue chips can still be overpriced. The best REITs are often quality names facing temporary issues. These REITs may offer yield and upside today.
Ingelheim, Germany and Shanghai , China /Cambridge, Mass. – 15 April , 202 6 – Boehringer Ingelheim and Zai Lab (NASDAQ: ZLAB; HKEX: 9688) today announced a clinical collaboration
Samsung Bioepis Initiates Phase 1 Clinical Trial for SBE303, Nectin-4 Targeting Antibody-Drug Conjugate (ADC) Candidate
08:00am, Tuesday, 14'th Apr 2026
INCHEON, Korea--(BUSINESS WIRE)-- #ADC--Samsung Bioepis Co., Ltd. announced today the initiation of Phase 1 clinical trial for SBE303. SBE303 is Samsung Bioepis's first novel antibody-drug conjugate (
A Fragile Truce
09:00am, Sunday, 12'th Apr 2026
U.S. equity markets extended their rebound this week as investors welcomed tentative progress toward de-escalation in the Middle East following several days of dramatic threats of significant escalati
Agree Realty Declares Increased Monthly Common Dividend
04:05pm, Thursday, 09'th Apr 2026
ROYAL OAK, Mich.--(BUSINESS WIRE)--Agree Realty Corporation (NYSE: ADC) (the “Company”) today announced that its Board of Directors has authorized, and the Company has declared, a monthly cash div
My Dividend Growth Income: March 2026 Update
10:04pm, Wednesday, 08'th Apr 2026
I achieved a record $912.86 in monthly dividends and added $308.68 in forward income, reaching $6,883.46 in annual projected dividends. New capital contributions and purchases, particularly in SPYI an
I'm Buying Up To 10% Yield For Monthly Income
08:45am, Monday, 06'th Apr 2026
Gladstone Capital offers a 10.1% well-covered monthly yield, trading at a 15% discount to NAV with strong balance sheet and low non-accruals. GLAD's portfolio is anchored in secured debt, avoids softw
Strategic Partnership Enables Akari to Accelerate IND Filing By Late 2026 Strategic Partnership Enables Akari to Accelerate IND Filing By Late 2026
Don't Put All Your REIT Eggs In One Basket
10:05am, Sunday, 05'th Apr 2026
REITs deserve a larger allocation today, driven by attractive valuations, structural demand, and reliable income across diverse sectors. Data center REITs like Equinix, Digital Realty, and Iron Mounta
Agree Realty Corporation (NYSE:ADC) Given Consensus Recommendation of “Moderate Buy” by Brokerages
04:08am, Saturday, 04'th Apr 2026
Shares of Agree Realty Corporation (NYSE: ADC - Get Free Report) have received an average rating of "Moderate Buy" from the fifteen analysts that are covering the stock, MarketBeat reports. Six equiti
Agree Realty: Trading At An Appropriate Premium To Invested Capital
09:15am, Thursday, 02'nd Apr 2026
Agree Realty Corporation (ADC) maintains a healthy investment spread, earning a 7.2% cap rate versus a 6.24% WACC, supporting accretive growth. ADC's muted beta of 0.72 and investment-grade tenant mix
